Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.

Alumis and Acelyrin had merger talks in 2023 before current deal. SEC filing shows earlier reverse merger attempt, followed ...

A new study explores gaps in how patients and physicians view psoriatic arthritis (PsA) and recommends ways for clinicians to ...

Alumis and Kaken Pharmaceutical have entered a partnership and licensing agreement for the development of the former’s ...

Shares of Alumis (NASDAQ:ALMS) traded ~14% higher in the premarket on Tuesday after the California-based biopharma announced ...

Acelyrin (NASDAQ:SLRN – Get Free Report) is projected to issue its quarterly earnings data before the market opens on ...

Drug development company Acelyrin Inc. recently saw a modest increase in its stock price after announcing the adoption of a ...

Explore in-depth articles on specialized and primary care, surgery, experimental medicine, and cancer.

Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to robust long-term clinical responses and was well tolerated ...

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; Alkeus Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals ...

We recently published a list of 10 Best Short-Term Stocks To Buy Right Now. In this article, we are going to take a look at where Acelyrin, Inc. (NASDAQ:SLRN) stands against other best short-term ...